Jason Case, the vice president of research and development for Medtronic’s acute care and monitoring division, said ...

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change ...

Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.

Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Medtronic plc (NYSE:MDT – Get Free Report) was the target of unusually large options trading on Friday. Traders acquired ...

with Medtronic offering $738 million for the business, saying it would combine EOFlow’s tubeless, wearable, and fully disposable EOPatch with its continuous glucose monitor (CGM) devices and ...

Medtronic recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by the release of promising five-year data from the Evolut Low Risk Trial, which ...

Diabetes business represents around 7.7% of total revenue, growing at double-digit in the recent quarters, driven by strong demand for Medtronic’s Continuous Glucose Monitoring (CGM) solutions.